ZOTA HEALTH CARE LIMITED·PHARMACEUTICALS 70.24·Pharmaceuticals & Biotechnology Companies

2026-08-21 NSE Web Result 14 Aug

Price

1,087.4

+0.99%
O:1080
H:1096.8
L:1064.6
C:1087.4

52W Range

1026.21740
+6%/-38%

Market Cap

₹3,765.95 Cr

Traded: ₹6.19 Cr (0.16%) 0.0x

Free Float: ₹1,022.83 Cr (0.61% of FF traded)

Volume · 60D trend

57.26 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:-15% 3M:-17% 6M:-18% 12M:-35%

Valuation

P/E--
P/B5.4
P/S6.2
EV/EBIT195.0

Business Strength

ROE-36.0%
ROCE-17.0%
OPM3.5%
NPM-13.7%

Growth (3Y CAGR)

EPS-8.4%
Sales+57.0%
Profit--
3Y Return+40.0%

Balance Sheet

Debt/Equity0.0
Debt28 Cr
Pledge0.3%
CWIP/Fixed Asset0.5%

Cash Position

CFO/NP113.5%
FCF-197 Cr
FCF 3Y Avg-316 Cr
Cash/MCap1.0%

Others

Div Yield0.1%
Div Payout-5.0%
Cash Conv. Cycle200 days
Tradeable Free Float27.2%

MTF Exposure Trend

60 sessions · funded amount, % of FF, daily delta

Current
₹ 29.17 Cr
2.85% FF
60d high
₹ 36.47 Cr
60d low
₹ 28.48 Cr
60d mean
₹ 32.44 Cr
vs mean
▼ 10.08%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
Sales
--
+38.0%
+57.0%
--
+79.0%
Accelerating
ROE
--
-16.0%
-20.0%
--
--
Decelerating
Return
--
+30.0%
+40.0%
-10.0%
--
Stable
Profit
--
--
--
--
-69.0%
--

Quarterly Results

Jun 2026

14 Aug
Rev
174 Cr
+67% YoY+7% QoQ
OPM-7.0%
NPM-25.3%
PAT
-204% YoY-44 Cr
EPS
-162% YoY-12.6

Mar 2026

PDF
Rev
163 Cr
+68% YoY+14% QoQ
OPM5.0%
NPM-8.6%
PAT
+31% YoY-14 Cr
EPS
+9% YoY-4.1

Dec 2025

4 Feb
Rev
143 Cr
+99% YoY+11% QoQ
OPM-0.3%
NPM-21.0%
PAT
-58% YoY-30 Cr
EPS
-29% YoY-8.7

Sep 2025

PDF
Rev
129 Cr
+93% YoY+24% QoQ
OPM4.9%
NPM-12.4%
PAT
-32% YoY-16 Cr
EPS
-18% YoY-5.2

Jun 2025

PDF
Rev
104 Cr
+86% YoY+7% QoQ
OPM3.8%
NPM-13.5%
PAT
-13% YoY-14 Cr
EPS
-0% YoY-4.8

Mar 2025

PDF
Rev
97 Cr
+94% YoY+35% QoQ
OPM2.5%
NPM-13.4%
PAT
-86% YoY-13 Cr
EPS
-68% YoY-4.5

Dec 2024

PDF
Rev
72 Cr
+53% YoY+7% QoQ
OPM-8.0%
NPM-26.4%
PAT
-535% YoY-19 Cr
EPS
-495% YoY-6.8

Sep 2024

PDF
Rev
67 Cr
+49% YoY+20% QoQ
OPM-1.3%
NPM-17.9%
PAT
-633% YoY-12 Cr
EPS
-589% YoY-4.4

Jun 2024

PDF
Rev
56 Cr
+44% YoY+12% QoQ
OPM-2.2%
NPM-23.2%
PAT
-348% YoY-13 Cr
EPS
-324% YoY-4.8

Mar 2024

PDF
Rev
50 Cr
+35% YoY+6% QoQ
OPM-3.0%
NPM-14.0%
PAT
-119% YoY-7 Cr
EPS
-155% YoY-2.7

Dec 2023

PDF
Rev
47 Cr
+34% YoY+4% QoQ
OPM7.0%
NPM-6.4%
PAT
+9% YoY-3 Cr
EPS
+11% YoY-1.1

Sep 2023

PDF
Rev
45 Cr
+15% YoY+15% QoQ
OPM10.0%
NPM-4.4%
PAT
-281% YoY-2 Cr
EPS
-278% YoY-0.6

Jun 2023

PDF
Rev
39 Cr
--+5% QoQ
OPM3.3%
NPM-7.7%
PAT
-246% YoY-3 Cr
EPS
---1.1

Mar 2023

PDF
Rev
37 Cr
--+6% QoQ
OPM3.0%
NPM-8.1%
PAT
-213% YoY-3 Cr
EPS
---1.1

Dec 2022

Rev
35 Cr
---10% QoQ
OPM0.0%
NPM-8.6%
PAT
-197% YoY-3 Cr
EPS
---1.3

Sep 2022

Rev
39 Cr
----
OPM12.0%
NPM2.6%
PAT
-72% YoY1 Cr
EPS
--0.4

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.39
Interest Coverage-0.5x
Promoter Pledge0.3%
Borrowings270 Cr

Efficiency

Receivable Days50 days
Inventory Days329 days
Payable Days178 days
Cash Conversion cycle200 days

Cash Position

Operating Cash Flow-84 Cr
Investing Cash Flow-314 Cr
Financing Cash Flow490 Cr
Free Cash Flow-197 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2023PDF ↗
Sep 2023PDF ↗
Jun 2023PDF ↗
Mar 2023PDF ↗
Dec 2022
Sep 2022
Sales1741631431291049772675650474539373539
Expenses1851541431231009578685851444137363534
Operating Profit-1290642-6-1-1-1341105
OPM %-7.0%5.0%-0.3%4.9%3.8%2.5%-8.0%-1.3%-2.2%-3.0%7.0%10.0%3.3%3.0%0.0%12.0%
Other Income2-322111100000111
Interest6554332332111111
Depreciation282722191514111087553433
Profit Before Tax-44-26-26-14-13-14-18-13-12-10-3-1-3-3-32
Tax %1.0%-45.0%14.0%13.0%5.0%-10.0%2.0%-4.0%5.0%-27.0%7.0%49.0%1.0%-15.0%-4.0%58.0%
Net Profit-44-14-30-16-14-13-19-12-13-7-3-2-3-3-31
Exceptional Items0-600000000000100
EPS (Rs)-12.6-4.1-8.7-5.2-4.8-4.5-6.8-4.4-4.8-2.7-1.1-0.6-1.1-1.1-1.30.4
Sales Growth (YoY)67.3%68.0%98.6%92.5%85.7%94.0%53.2%48.9%43.6%35.1%34.3%15.4%--------
Sales Growth (QoQ)6.8%14.0%10.8%24.0%7.2%34.7%7.5%19.6%12.0%6.4%4.4%15.4%5.4%5.7%-10.3%--
OP Growth (YoY)-400.0%350.0%100.0%700.0%500.0%300.0%-300.0%-125.0%-200.0%-200.0%---20.0%--------
OP Growth (QoQ)-233.3%---100.0%50.0%100.0%133.3%-500.0%0.0%0.0%-133.3%-25.0%300.0%0.0%---100.0%--
Profit Growth (YoY)-204.0%31.0%-58.0%-32.0%-13.0%-86.0%-535.0%-633.0%-348.0%-119.0%9.0%-281.0%-246.0%-212.9%-197.0%-71.7%
EPS Growth (YoY)-161.5%9.1%-28.8%-17.9%-0.4%-67.9%-494.7%-589.1%-323.9%-155.2%10.9%-277.8%--------
EPS Growth (QoQ)-207.6%53.1%-67.9%-8.1%-6.9%33.6%-53.7%7.9%-78.7%-135.1%-78.1%43.4%-7.6%18.0%-455.6%--
OP Margin-6.9%5.5%0.0%4.7%3.9%2.1%-8.3%-1.5%-1.8%-2.0%6.4%8.9%2.6%2.7%0.0%12.8%
Net Margin-25.3%-8.6%-21.0%-12.4%-13.5%-13.4%-26.4%-17.9%-23.2%-14.0%-6.4%-4.4%-7.7%-8.1%-8.6%2.6%
Material Cost %38.0%36.5%39.7%40.7%43.6%49.2%44.1%46.5%46.8%45.9%54.1%54.9%61.3%56.1%61.3%60.3%
Employee Cost %35.2%33.4%36.7%29.6%32.0%26.7%33.0%29.8%28.9%24.4%16.5%13.2%11.9%12.2%8.2%7.1%
P/S6.187.989.0710.03------------------------
P/E--------------------------------
P/B5.436.1913.5812.76------------------------

Shareholding Pattern

Shareholders:14.7K (+102.9%)
Current MixJun 2026

Annual Reports

7

2025

2024

2023

2022

2021

2020

2019

Concalls

27

Feb 2026

28 Feb 2026

Nov 2025

30 Nov 2025

Oct 2025

31 Oct 2025

Aug 2025

31 Aug 2025

Jul 2025

31 Jul 2025

Jun 2025

30 Jun 2025

Apr 2025

30 Apr 2025

Feb 2025

28 Feb 2025

Nov 2024

30 Nov 2024

Aug 2024

31 Aug 2024

May 2024

31 May 2024

Feb 2024

29 Feb 2024

Nov 2023

30 Nov 2023

Jun 2023

30 Jun 2023

Feb 2023

28 Feb 2023

Nov 2022

30 Nov 2022

Sep 2022

30 Sept 2022

Jun 2022

30 Jun 2022

Feb 2022

28 Feb 2022

Dec 2021

31 Dec 2021

Aug 2021

31 Aug 2021

Jun 2021

30 Jun 2021

Feb 2021

28 Feb 2021

Dec 2020

31 Dec 2020

Sep 2020

30 Sept 2020

Jun 2020

30 Jun 2020

Feb 2020

29 Feb 2020

Held by Mutual Funds

2 schemes hold ZOTA · sorted by weight

#SchemeWeight %
1

WhiteOak Capital Special Opportunities Fund

WhiteOak Capital Mutual Fund

0.75%
2

WhiteOak Capital Pharma and Healthcare Fund

WhiteOak Capital Mutual Fund

0.52%